Loading provider…
Loading provider…
Rheumatology Physician in Pittsburgh, PA
NPI: 1093868960Primary Practice Location
UPMC PRESBYTERIAN SHADYSIDE
3459 5th Ave, Pittsburgh, PA
Primary Employer
University of Pittsburgh Physicians
chp.edu
HQ Phone
Get MD Andreea's Phone Numberphone_androidMobile
Get MD Andreea's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 33 | 42 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 12 | 12 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 11 | 11 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 11 | 11 |
Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjogren's Syndrome.
Authors: Ching, K H, Burbelo, P D, Gonzalez-Begne, M, Roberts, M E P, Coca, A, Sanz, I, Iadarola, M J
Journal: J Dent Res
Publication Date: 2011-01-06
Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus.
Authors: Elena Massarotti, Fotios Koumpouras, Meggan Mackay, Ellen Goldmuntz, Peter Gregersen, Lisa Criscione-Schreiber
Publication Date: 2014-10-03
Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells.
Authors: Craig Maguire, Jennifer Anolik
Publication Date: 2014-01-19
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib